Christopher Butterfield

Christopher Butterfield serves as a primary contracting professional within the Animal and Plant Health Inspection Service (APHIS) under the U.S. Department of Agriculture, based in Kansas City, Missouri. In this role, he supports the agency’s mission to protect U.S. agricultural health by managing the acquisition of scientific, diagnostic, and surveillance technologies critical to detecting and mitigating exotic pests, invasive species, and transboundary animal diseases. His procurement activities center on high-stakes, science-driven acquisitions including laboratory equipment, biocontainment systems, field diagnostic kits, and data analytics platforms used in national surveillance networks. He ensures compliance with federal procurement regulations while aligning contract strategies with APHIS’s operational priorities in biosecurity and rapid response readiness. Butterfield collaborates with a diverse ecosystem of contractors, including specialized biotechnology firms, analytical instrument manufacturers, and federal scientific service providers. His working relationships emphasize technical proficiency and regulatory compliance, often engaging vendors with expertise in biosafety level (BSL) infrastructure, molecular diagnostics, and real-time pathogen tracking systems. While specific contractor names are not publicly enumerated, his procurement pattern reflects a preference for vendors with proven experience in federal biosecurity programs and demonstrated capacity to meet stringent USDA and USDA-APHIS quality assurance standards. Though set-aside data is not currently available, Butterfield’s alignment with APHIS’s broader mission suggests a strong inclination toward socioeconomic contracting, including support for 8(a), HUBZone, and SDVOSB firms capable of delivering specialized scientific services. His contracting approach likely integrates small business participation as a strategic lever to enhance innovation and regional capacity in agricultural biosecurity. His industry focus is rooted in NAICS categories related to scientific research and development, laboratory services, and medical device manufacturing—particularly those supporting pathogen detection, genomic sequencing, and field-based surveillance. He routinely procures advanced analytical instruments, biosensors, data management systems, and mobile diagnostic units essential to APHIS’s frontline response capabilities.